Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-07 | Future report Set alerts | |
Q2 2022 | 2022-07-28 | -0.10 | -0.10 |
Q1 2022 | 2022-05-05 | -0.24 | -0.24 |
Q4 2021 | 2022-02-09 | -0.20 | -0.20 |
Q3 2021 | 2021-11-09 | -0.23 | -0.23 |
Q2 2021 | 2021-07-29 | -0.09 | -0.09 |
Q1 2021 | 2021-04-28 | -0.12 | -0.12 |
Q4 2020 | 2021-02-11 | -0.06 | -0.06 |
Q3 2020 | 2020-10-27 | -0.24 | -0.77 |
Q2 2020 | 2020-07-30 | -0.34 | -1.03 |
2016-05-08 | Reiterated Rating | Oppenheimer | Buy | |
2016-05-08 | Reiterated Rating | Robert W. Baird | Buy | |
2016-05-08 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
2016-05-06 | Reiterated Rating | Credit Suisse | Buy | |
2016-05-06 | Reiterated Rating | Credit Suisse Group AG | Buy | |
2016-04-20 | Reiterated Rating | Robert W. Baird | Buy | |
2016-04-07 | Reiterated Rating | Credit Suisse | Buy | $32.00 |
2016-02-27 | Reiterated Rating | Oppenheimer | Buy | |
2016-02-26 | Lower Price Target | Oppenheimer | Outperform | $35.00 to $29.00 |
2016-02-26 | Reiterated Rating | Needham & Company LLC | Buy | $41.00 to $31.00 |
2016-02-26 | Lower Price Target | Compass Point | Buy | $40.00 to $36.00 |
2016-02-22 | Lower Price Target | Pacific Crest | Overweight | $38.00 to $32.00 |
2015-11-10 | Reiterated Rating | Compass Point | Buy | $40.00 |
2015-10-27 | Lower Price Target | Oppenheimer | Outperform | $40.00 to $35.00 |
2015-10-27 | Reiterated Rating | Compass Point | Buy | |
2015-10-16 | Upgrade | Goldman Sachs | Neutral to Buy | |
2015-10-16 | Upgrade | Goldman Sachs Group Inc. | Neutral to Buy | |
2015-10-13 | Reiterated Rating | First Analysis | Overweight | $42.00 |
2015-10-09 | Reiterated Rating | Pacific Crest | Overweight | $38.00 |
2015-10-05 | Reiterated Rating | Compass Point | Buy | $40.00 |
2015-09-28 | Initiated Coverage | Credit Suisse | Outperform | $40.00 to $35.21 |
2015-08-13 | Boost Price Target | Oppenheimer | Outperform | $35.00 to $40.00 |
2015-08-07 | Boost Price Target | BMO Capital Markets | $37.00 to $40.00 | |
2015-08-07 | Reiterated Rating | Oppenheimer | Outperform | $29.00 to $35.00 |
2015-08-07 | Reiterated Rating | Needham & Company LLC | Buy | $30.00 to $41.00 |
2015-08-07 | Boost Price Target | Compass Point | Buy | $31.00 to $40.00 |
2015-07-15 | Boost Price Target | Pacific Crest | Overweight | $31.00 to $38.00 |
2015-07-15 | Initiated Coverage | Robert W. Baird | Outperform | $35.00 |
2015-06-26 | Boost Price Target | BMO Capital Markets | Outperform | $32.00 to $37.00 |
2015-05-08 | Set Price Target | Compass Point | Buy | $29.00 to $31.00 |
2015-05-08 | Boost Price Target | Pacific Crest | Overweight | $24.00 to $31.00 |
2015-05-08 | Boost Price Target | Oppenheimer | Outperform | $27.00 to $29.00 |
2015-05-04 | Boost Price Target | Credit Suisse | Outperform | $24.00 to $35.00 |
2015-05-04 | Boost Price Target | Needham & Company LLC | Buy | $22.00 to $30.00 |
2015-04-01 | Boost Price Target | Oppenheimer | Outperform | $22.00 to $27.00 |
2015-03-31 | Boost Price Target | Compass Point | Buy | $23.00 to $29.00 |
2015-02-27 | Boost Price Target | Oppenheimer | Outperform | $20.00 to $22.00 |
2015-02-27 | Boost Price Target | Pacific Crest | Outperform | $23.00 to $24.00 |
2014-12-02 | Initiated Coverage | BMO Capital Markets | Outperform | |
2014-11-05 | Reiterated Rating | Barrington Research | Outperform | $20.00 to $22.00 |
2014-11-05 | Initiated Coverage | Pacific Crest | Buy | $20.00 to $23.00 |
2014-11-05 | Boost Price Target | Oppenheimer | Outperform | $18.00 to $20.00 |
2014-11-05 | Reiterated Rating | Compass Point | Buy | $20.00 to $23.00 |
2014-10-09 | Initiated Coverage | Pacific Crest | Outperform | $20.00 |
2014-08-11 | Downgrade | Goldman Sachs | Buy to Neutral | $18.00 |
2014-08-07 | Boost Price Target | Compass Point | Buy | $18.00 to $20.00 |
2014-07-25 | Initiated Coverage | Credit Suisse | Positive to Outperform | $20.00 |
2014-07-25 | Initiated Coverage | Barrington Research | Outperform | $20.00 |
2014-06-30 | Initiated Coverage | First Analysis | Overweight | |
2014-05-16 | Reiterated Rating | Needham & Company LLC | Buy | $18.00 |
2014-05-16 | Reiterated Rating | Goldman Sachs | Buy | $17.00 |
2014-05-13 | Reiterated Rating | Compass Point | Buy | |
2014-05-08 | Reiterated Rating | Needham & Company LLC | Buy | $18.00 |
2014-05-08 | Reiterated Rating | Goldman Sachs | Buy | $17.00 |
2014-04-30 | Reiterated Rating | Needham & Company LLC | Buy | $18.00 |
2014-04-30 | Reiterated Rating | Goldman Sachs | Buy | $17.00 |
2014-04-22 | Initiated Coverage | Needham & Company LLC | Buy | $18.00 |
2014-04-22 | Initiated Coverage | Oppenheimer | Outperform | $18.00 |
2014-04-22 | Initiated Coverage | Pacific Crest | Outperform | |
2014-04-22 | Initiated Coverage | Credit Suisse | Outperform | $20.00 |
2014-04-22 | Initiated Coverage | Goldman Sachs | Outperform to Buy | $17.00 |
2014-04-21 | Initiated Coverage | Compass Point | Buy | $18.00 |
2016-05-08 | Reiterated Rating | Oppenheimer | Buy | |
2016-05-08 | Reiterated Rating | Robert W. Baird | Buy | |
2016-05-08 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
2016-05-06 | Reiterated Rating | Credit Suisse | Buy | |
2016-05-06 | Reiterated Rating | Credit Suisse Group AG | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In TWOU 158 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Vanguard Group, Inc | 7.15M |
BlackRock Inc. | 6.09M |
Nikko Asset Management Americas, Inc. | 5.52M |
Sumitomo Mitsui Trust Holdings, Inc. | 5.52M |
MORGAN STANLEY | 4.17M |
D. E. Shaw & Co., Inc. | 2.42M |
Arrowpoint Asset Management, LLC | 2.06M |
CREDIT SUISSE AG/ | 1.65M |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1.61M |
STATE STREET CORP | 1.56M |
GEODE CAPITAL MANAGEMENT, LLC | 1.39M |
NORDEA INVESTMENT MANAGEMENT AB | 1.28M |
CITADEL ADVISORS LLC | 1.15M |
Invesco Ltd. | 1.14M |
BlackRock Fund Advisors | 1.10M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Novak Biddle Venture Partners V L P | 8.48% (3413330) | TWOU / |
KATZMAN JOHN S | 3.20% (1288695) | TWOU / |
COHEN ROBERT Chief Operating Officer | 0.89% (358299) | TWOU / |
Highland Management Partners VII, LLC | 0.79% (319914) | GIMO / HPTX / TWOU / |
Paucek Christopher J Chief Executive Officer | 0.49% (196191) | TWOU / |
STAVIS ROBERT M | 0.29% (115315) | TWOU / |
GRAHAM CATHERINE A Chief Financial Officer | 0.18% (73837) | TWOU / |
MAEDER PAUL A | 0.13% (50866) | IMPR / TWOU / |
Kenigsberg James Chief Technology Officer | 0.11% (43180) | TWOU / |
Mokkarala Harsha Chief Marketing Officer | 0.10% (41182) | TWOU / |
Rinehart Jeff C Chief Marketing Officer | 0.10% (38295) | TWOU / |
Cates Susan E. Chief Operating Officer | 0.09% (37126) | PRMW / TWOU / |
Shelton James H Chief Impact Officer | 0.05% (21193) | TWOU / |
KRAWCHECK SALLIE | 0.05% (21066) | TWOU / |
Macias Edward S. | 0.05% (19777) | TWOU / |
Lewis Earl | 0.05% (18273) | TWOU / |
LARSON JOHN M | 0.04% (17206) | TWOU / |
CHERNIS MARK | 0.04% (15325) | TWOU / |
Papaconstantopoulos Andrea SVP, Corp Controller & CAO | 0.03% (11043) | TWOU / |
Sutphen David Chief Communications Officer | 0.02% (7100) | TWOU / |
Rushing Coretha M | 0.01% (5906) | EFX / TWOU / |
HALEY TIMOTHY M | 0.01% (5649) | NFLX / TWOU / |
Hammond Rani Chief People Officer | 0.01% (5604) | TWOU / |